Literature DB >> 18020454

Anti-idiotypic antibody mimics proteolytic function of parent antigen.

Natalia A Ponomarenko1, Dominique Pillet, Marjorie Paon, Ivan I Vorobiev, Ivan V Smirnov, Hervé Adenier, Bérangère Avalle, Alexander V Kolesnikov, Arina V Kozyr, Daniel Thomas, Alexander G Gabibov, Alain Friboulet.   

Abstract

Functional imaging of subtilisin Carlsberg active center by the idiotypic network yielded a catalytic anti-idiotypic antibody with endopeptidase, amidase, and esterase activities. A monoclonal antibody inhibitory to subtilisin (Ab1 5-H4) was employed as the template for guiding the idiotypic network to produce the catalytic anti-idiotypic Ab2 6B8-E12. Proteolytic activity of 6B8-E12 was demonstrated by zymography using self-quenched fluorescein-BSA conjugate and in a coupled assay detecting Ab2-dependent RNase A inactivation. Cleavage of peptide substrates by 6B8-E12 revealed distinct patterns of hydrolysis with high preference for aromatic residues before or after the scissile bond. Catalytic activity of Ab2 was inhibited by phenylmethylsulfonyl fluoride, a mechanism-based inhibitor of serine hydrolases. 5-H4 and 6B8-E12 were cloned, produced in Escherichia coli as single-chain variable fragments (scFvs), and purified. Kinetic parameters for amidolytic and esterolytic activities were similar in Ab2 and its scFv derivative. Although the antigen-specific portion of 6B8-E12 possesses no primary structure similarity to subtilisin, it mimics proteolytic and amidolytic functions of the parental antigen, albeit with 4 orders of magnitude slower acceleration rates. The lack of detectable endopeptidase activity of 6B8-E12 scFv raises interesting issues concerning general evolution of catalytic activity. The in silico 3D models of Ab1 and Ab2 revealed strong structural similarity to known anti-protease antibodies and to abzymes, respectively. These results indicate that the idiotypic network is capable, to a significant extent, of reproducing catalytic apparatus of serine proteases and further validate the use of imaging of enzyme active centers by the immune system for induction of abzymes accelerating energy-demanding amide bond hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18020454     DOI: 10.1021/bi7013954

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Molecular imprint of enzyme active site by camel nanobodies: rapid and efficient approach to produce abzymes with alliinase activity.

Authors:  Jiang-Wei Li; Lijie Xia; Youhong Su; Hongchun Liu; Xueqing Xia; Qinxia Lu; Chunjin Yang; Kalbinur Reheman
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

2.  Anti-idiotypic Fab Fragments Image a Conserved N-terminal Epitope Patch of Grass Pollen Allergen Phl p 1.

Authors:  Anna Lukschal; Jan Fuhrmann; Juryj Sobanov; Dirk Neumann; Julia Wallmann; Regina Knittelfelder; Wolfgang Hemmer; Otto Scheiner; Monique Vogel; Beda M Stadler; Erika Jensen-Jarolim; Krisztina Szalai
Journal:  Open Allergy J       Date:  2011-05-23

3.  The antiidiotypic approach to obtaining a proteolytic antibody.

Authors:  I V Smirnov; I I Vorobiev; A Friboulet; B Avalle; D Thomas; V D Knorre; A G Gabibov; N A Ponomarenko
Journal:  Dokl Biochem Biophys       Date:  2008 May-Jun       Impact factor: 0.788

4.  Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.

Authors:  Chiou-Miin Wang; Sarah Devries; Marybeth Camboni; Matthew Glass; Paul T Martin
Journal:  Neurobiol Dis       Date:  2010-05-20       Impact factor: 5.996

5.  Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice.

Authors:  Alexander V Mayorov; Neri Amara; Jason Y Chang; Jason A Moss; Mark S Hixon; Diana I Ruiz; Michael M Meijler; Eric P Zorrilla; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

6.  Excessive Labeling Technique Provides a Highly Sensitive Fluorescent Probe for Real-time Monitoring of Biodegradation of Biopolymer Pharmaceuticals in vivo.

Authors:  S S Terekhov; I V Smirnov; O G Shamborant; M A Zenkova; E L Chernolovskaya; D V Gladkikh; A N Murashev; I A Dyachenko; V D Knorre; A A Belogurov; N A Ponomarenko; S M Deyev; V V Vlasov; A G Gabibov
Journal:  Acta Naturae       Date:  2014-10       Impact factor: 1.845

7.  Anti-idiotypic antibodies: a new approach in prion research.

Authors:  Anja Colja Venturini; Maja Bresjanac; Tanja Vranac; Simon Koren; Mojca Narat; Mara Popović; Vladka Curin Serbec
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

8.  Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.

Authors:  Emi Hifumi; Naoko Fujimoto; Mitsue Arakawa; Eri Saito; Shingo Matsumoto; Nobuyuki Kobayashi; Taizo Uda
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

9.  Role of κ→λ light-chain constant-domain switch in the structure and functionality of A17 reactibody.

Authors:  Natalia Ponomarenko; Spyros D Chatziefthimiou; Inna Kurkova; Yuliana Mokrushina; Yuliana Mokrushina; Anastasiya Stepanova; Ivan Smirnov; Marat Avakyan; Tatyana Bobik; Azad Mamedov; Vladimir Mitkevich; Alexey Belogurov; Olga S Fedorova; Michael Dubina; Andrey Golovin; Victor Lamzin; Alain Friboulet; Alexander A Makarov; Matthias Wilmanns; Alexander Gabibov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-15

10.  Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States.

Authors:  Evgeny A Ermakov; Georgy A Nevinsky; Valentina N Buneva
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.